
Mar 1, 2025, 10:17
Myeloma Paper of the Day, March 1st, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Bone marrow NK cell profile predicts MRD negativity in myeloma patients treated with dara-based therapy; low proportion of CD16+ BM NK cells with decreased cytokine production and degranulation associated with reduced MRD-negativity.”
Authors: Charlotte Korst, Sabrin Tahri, Carolien Duetz, Tom Cupedo, Niels van de Donk et al.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22